杨雅坤, 盛莉, 李燕. 黄素单氧化酶在药物代谢和新药研发中的作用J. 药学学报, 2017,52(10): 1485-1495. doi: 10.16438/j.0513-4870.2017-0231
引用本文: 杨雅坤, 盛莉, 李燕. 黄素单氧化酶在药物代谢和新药研发中的作用J. 药学学报, 2017,52(10): 1485-1495. doi: 10.16438/j.0513-4870.2017-0231
YANG Ya-kun, SHENG Li, LI Yan. Role of FMOs in drug metabolism and developmentJ. Acta Pharmaceutica Sinica, 2017,52(10): 1485-1495. doi: 10.16438/j.0513-4870.2017-0231
Citation: YANG Ya-kun, SHENG Li, LI Yan. Role of FMOs in drug metabolism and developmentJ. Acta Pharmaceutica Sinica, 2017,52(10): 1485-1495. doi: 10.16438/j.0513-4870.2017-0231

黄素单氧化酶在药物代谢和新药研发中的作用

Role of FMOs in drug metabolism and development

  • 摘要: 黄素单氧化酶(flavin-containing monooxygenases,FMOs)是仅次于细胞色素P450(cytochrome P450,CYP450)的重要Ⅰ相代谢酶,可催化含氮、硫、磷、硒等亲核杂原子的外源物及部分内源物的氧化反应。本文将介绍FMOs的生物学特征、催化机制、底物特异性、基因多态性,分析FMOs对药物代谢的影响和个体差异以及与FMOs代谢相关的疾病,为寻找新的作用靶点和设计候选药物提供理论参考。

     

    Abstract: The flavin-containing monooxygenase (FMOs) is recognized as an important complimentary enzyme system next to the cytochrome P450 (CYP450), which catalyzes the metabolism of many xenobiotics (nucleophilic heteroatom-containing chemicals) and several endobiotics. This article provides a comprehensive introduction of FMOs including the biological characteristics, catalytic mechanism, substrate specificity, genetic polymorphisms. The effect of FMOs on drug metabolism and individual differences and relation with diseases are also mentioned. It is valuable for the discovery of therapeutic targets and design of new drug candidate.

     

/

返回文章
返回